A discussion of the changing medtech markets and how companies can remain cognizant of potentially disruptive changes in their business and industry for future success in their product portfolios, services and relationships.
ECRI releases its top 10 list of health technology hazards for 2018.
The agency is seeking more participation among different genders, ages, races and ethnic groups.
Do regulators have a disincentive to approve medical devices?
Device companies can tap into a growing market that needs more cost effective healthcare services.
Discussing device problems can have a serious affect on patients. Physicians, manufacturers, and FDA should clarify their message to maintain trust.
These violators have caused serious injury or death to patients. Here we focus on AM2PAT’s former president, Dushyant Mahendrabhai Patel.
Success metrics in an accountable care organization (ACO) can be extensive in scope, from quality to cost to utilization to patient satisfaction—and all of these factors are important.